Evidence map›Paper›PMID 22257949›Full record

ReviewNature reviews. Cancer2012

Are snoRNAs and snoRNA host genes new players in cancer?

Gwyn T Williams, Farzin Farzaneh

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Cancer, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 232 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
232citing papers in PubMed, 2 pooled it
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

232 citing papers in PubMed, 2 syntheses or guidelines pooled it, 366 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. LncRNA SNHG3: a potential biomarker for human diseases.Frontiers in cell and developmental biology · 2026
    Review
  10. Review
  11. Article
  12. Review
  13. Translational cancer research · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Chemically modified non-coding RNAs in cancer.Expert reviews in molecular medicine · 2025
    Review
  18. EGFR-induced lncRNAProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  19. Review
  20. Article

172 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Gwyn T WilliamsInstitute for Science and Technology in Medicine, Huxley Building, Keele University, Keele ST5 5BG, UK. g.t.williams@keele.ac.uk
Farzin Farzaneh
Keele University · GBKing's College London · GB

Funding

Biotechnology and Biological Sciences Research Council BB/E005896/1Department of Health
6 · The paper itself

Abstract

Small nucleolar RNAs (snoRNAs) have long been considered important but unglamorous elements in the production of the protein synthesis machinery of the cell. Recently, however, several independent lines of evidence have indicated that these non-coding RNAs might have crucial roles in controlling cell behaviour, and snoRNA dysfunction could consequently contribute to oncogenesis in previously unsuspected ways.

Indexed as

AnimalsHumansNeoplasmsRNA Processing, Post-TranscriptionalRNA, Small NucleolarRNA, Small Nucleolar

Identifiers

PMID22257949
OpenAlexW2043841998

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.